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Abstract
Background: Ultrasound scanning during the 2nd or the 3rd trimester of pregnancy for fetal size disturbances
screening is heavily dependent of the choice of the reference chart. This study aimed to assess the agreement of
Salomon and the Intergrowth 21st equations in evaluating fetal biometric measurements in a rural area of Burkina
Faso, and to measure the effect of changing a reference chart.
Methods: Data collected in Nazoanga, Burkina Faso, between October 2010 and October 2012, during a clinical trial
evaluating the safety and efficacy of several antimalarial treatments in pregnant women were analyzed. We included
singleton pregnancies at 16–36 weeks gestation as determined by ultrasound measurements of fetal bi-parietal
diameter (BPD), head circumference (HC), abdominal circumference (AC) and femur length (FL). Expected mean and
standard deviation at a given gestational age was computed using equations from Salomon references and using
Intergrowth 21st standard. Then, z-scores were calculated and used subsequently to compare Salomon references with
Intergrowth 21st standards.
Results: The analysis included 276 singleton pregnancies.
Agreement was poor except for HC: mean difference − 0.01, limits of agreement − 0.60 and 0.59. When AC was used as
a surrogate of fetal size, switching from the reference of Salomon to the standards of Intergrowth 21st increased ten
times the proportion of fetuses above the 90th percentile: 2.9 and 31.2%, respectively.
Mean differences were larger in the third trimester than in the second trimester. However, agreement remained good
for HC in both trimesters.
Difference in the proportion of AC measurements above the 90th percentile using Salomon and Intergrowth 21st
equations was greater in the second trimester (2.6 and 36.3%, respectively) than in the third trimester (3.5 and 19.8%,
respectively). The greatest difference between the two charts was observed in the number of FL measurements
classified as large in the second trimester (6.8 and 54.2%, using Salomon and Intergrowth 21st equations, respectively).
Conclusion: The agreement between Intergrowth 21st and Salomon equations is poor apart from HC. This would
imply different clinical decision regarding the management of the pregnancy.
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Background
Ultrasound scanning during the 2nd or 3rd trimester of
pregnancy allows fetal anthropometrics measurement [1]
and screening for fetal size disturbances by comparison
to reference values [2, 3].
Biparietal diameter (BPD), head circumference (HC),
abdominal circumference (AC), and femur length (FL)
are the most commonly measured parameters [4, 5].
Abnormal fetal biometric measurements could reflect
underlying health issues like microcephalia, aneuploidy,
genetic syndrome of skeletal dysplasia [6].
Early detection of abnormal fetal size helps obstetri-
cian initiating further monitoring, planning and man-
aging delivery in terms of labor induction or caesarian
section [6, 7].
However, abnormal fetal size identification depends
heavily on the choice of reference values. There is more
than eighty references charts in the world [4]. A switch-
ing from one reference chart to another could raise ten-
fold the likeliness of identifying abnormal biometric
measurements [8]. This could lead to expensive and
stressful monitoring with additional investigations [8, 9].
Also, fetal size depends of ethnicity and use of inad-
equate reference may result in harmful medical decisions
[10, 11]. For example, there is a risk of fetal loss in cases
in which karyotype is demanded because of the invasive
sampling method used [8]. Screening for fetal size dis-
turbances using inappropriate reference chart may affect
research conclusions and health policies as well [8, 10].
Thus some authors recommended to use local reference
for screening in a specific population [11–14]. In high-
income countries, [4, 5] local biometric reference charts
were adopted. Clear guidelines and recommendations for
screening of abnormal fetal size and subsequent manage-
ment were also put in place [5, 15–21]. In low- and
middle-income countries (LMICs), and particularly in
sub-Saharan Africa, local charts are either lacking or not
implemented where available [22–25]. The latter mostly
refer to European charts [26], or charts preprogramed by
default in the ultrasound device software [11–14, 27].
In 2014, the international fetal and newborn growth
consortium for the twenty-first century (Intergrowth
21st) published fetal biometric standard equations based
on selected healthy pregnancies from eight countries
[10, 27]. The aim was to provide charts that could be
used anywhere in the world and to solve the issue of in-
adequate references [27]. Settings where local reference
charts are lacking or not implemented are likely to re-
place the charts they are currently using by this new
chart. However, knowing the variation between nomo-
grams in assessing fetal size and the clinical implication,
it would be cautious to check whether adaptation is
needed before adopting or replacing a chart in a specific
population [14].
In Burkina Faso, no locally-adapted fetal biometry
charts have been adopted or recommended in obstetric
ultrasound practice. Rather, French references or other
European references set by default in the ultrasound ma-
chines are used. Indeed in France, Salomon equations
were recommended until 2018 [28].
Both the Salomon and Intergrowth 21st equations
allow the calculation of a mean and a standard devi-
ation by gestational age and the computation of a
standardized z-score for the individual fetus. The ob-
jective of the present analysis was to assess the differ-
ence between z-scores derived from Salomon and
from Intergrowth 21st equations using fetal biometric
measurements in pregnant women from rural areas of
Burkina Faso, and to measure the effect of changing a
reference chart.
Methods
Study settings and population
The current dataset is from the trial “Safe and efficacious
artemisinin-based combination treatment for African
pregnant women with malaria” (PREGACT) conducted
from June 2010 to August 2013 [NCT00852423 (Clini-
calTrials.gov)]. The primary study evaluated the efficacy
and safety of four artemisinin-based combinations treat-
ment in women with malaria in the 2nd and 3rd trimes-
ter of pregnancy. The trial was implemented in four
countries, namely Burkina Faso, Ghana, Malawi, and
Zambia. Methods and results have been already pub-
lished [29, 30]. This analysis used data collected in
Nazoanga, Burkina Faso, where fetal biometric measure-
ments at inclusion by ultrasound were carried out, to ex-
clude women in the 1st trimester.
Ultrasound
This study was cross-sectional. Ultrasonographic exam-
ination of the pregnant women was performed once at
inclusion. However, three participants had their scan re-
peated a second time at screening to confirm gestational
age as per the quality assurance system put in place [31,
Table 1 General characteristics of the mothers
Age (years) 23 (20; 29)
Gravidity 3 (1; 4)
Parity 2 (0; 3)
Weight (kg) 54 ± 6
Height (cm) 162 ± 7
Body mass index (kg/m2) 20.5 ± 1.7
Symphysis-fundal height (cm) 24 (21; 28)
Gestational age (weeks) 25 (21; 29)
Hemoglobin (g/dL) 10.1 ± 1.2
Numbers are mean ± standard deviation or median (IQR)
IQR interquartile range
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32]. A Fukuda Denshi© portable ultrasound scanner
FFsonic UF-4100 with a 3.5MHz or 5.0 MHz probes was
used for transabdominal examination according to
woman’s thinness.
Four biometric parameters were measured. BPD and
HC were both obtained in a transverse view of the fetal
head with the following landmarks: midline echo corre-
sponding to the fax cerebri, its anterior third interrupted
by the cavum septi pellucidi, symmetry of thalami at
each side. BPD was measured from the inner to the
outer wall of the skull. HC measurement was realized by
placing an ellipse around the outer border of the skull.
AC was measured by applying the ellipse on the external
border of the abdomen in a cross-sectional plane show-
ing the stomach bulbe and the anterior third of the um-
bilical vein. FL measurement was obtained in a plane
where the femoral diaphysis was fully visible, with cali-
pers placed on the both ends. All measurements were
done according to specific standard operating proce-
dures [31, 32]. Gestational age in complete weeks was
automatically derived from the four anthropometric
measurements according to Hadlock formula [32, 33]
Fig. 1 Fetal biometry measurements by gestational age. a: Biparietal diameter. b: Abdominal circumference. c: Head circumference. d: Femur
length. Intergrowth 21: International fetal and newborn growth consortium for the twenty-first century. The numbers at the right of the boxplots
represented from the bottom to the top: the minimum without outliers, the first quartile, the median, the third quartile and the maximum without outliers
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Statistical analysis
Three participants have their scan repeated once at
screening to confirm gestational age as per the quality
assurance system [29, 30]. We took this into account by
averaging the two measurements for each biometric
parameter.
The expected mean and expected standard deviation
for BPD, HC, AC and FL for the gestational age were
computed for each fetus using equations from Salomon
[16] and Intergrowth 21st [27]. The z-scores [(Observed
value – Expected mean)/Expected SD] of the two equa-
tions were compared. Square-diagonal scatter plots were
Fig. 2 Number of standard deviations from the mean using Salomon or Intergrowth 21 eqs. a: Biparietal diameter. b: Abdominal circumference.
c: Head circumference. d: Femur length. Intergrowth 21: International fetal and newborn growth consortium for the twenty-first century. Dashed
horizontal and vertical grey lines referred to a z score of − 1.282 corresponding to the 10th centile. Solid horizontal and vertical grey lines referred
to a z score of 1.282 corresponding to the 90th centile. The black oblique line is the perfect concordance line where the z-scores from
Intergrowth 21st and Salomon equations are equal
Bihoun et al. BMC Pregnancy and Childbirth          (2020) 20:492 Page 4 of 12
drawn to allow visual evaluation of the relationship be-
tween the two sets of z-scores. All differences (Inter-
growth 21st z-score - Salomon z-score) were compared
using paired t test and Wilcoxon signed ranks test. A p-
value < 0.05 was considered as statistically significant.
Linear relationship was checked by performing linear re-
gression of Intergrowth 21st z-scores by Salomon z-
scores.
Level of agreement between the charts was checked
using Bland-Altman analysis. Individual scores averages
were plotted horizontally against their differences verti-
cally. Limits of agreement (LOA) were obtained by ap-
plying the following formula: mean of differences ±1.96
standard deviation.
A mean difference of zero and limits of agreement
within − 0.50 and 0.50 were considered as a good agree-
ment [34].
Reliability between the two charts was expressed by
the intraclass correlation coefficient (ICC), calculated
from a random effect one-way analysis of variance. Reli-
ability was considered as weak, good or excellent if ICC
values were < 0.40, between 0.40 and 0.75, or > 0.75,
respectively.
Abnormal measurement referred to either smallness (z
score < − 2.00 corresponding to the 2.5th centile, z
score < − 1.282 corresponding to the 10th centile) or
largeness (z-score > 1.282 corresponding to the 90th cen-
tile, or z-score > 2.00 corresponding to the 97.5th
centile).
The effect of replacing one chart with another was
measured using AC as a surrogate of fetal weight [2, 9].
STATA® statistical software version 15.1 StataCorp
LLC, Texas, USA, was used for all analyses.
Ethics
Ethical approvals were obtained for the PREGACT study
from the ethics committee of the University of Antwerp,
Belgium, the institutional ethics committee of the Centre
Muraz and the ethics committee of the Ministry of
Health, Burkina Faso. Study participants or their legally
authorized representative (for minors/not emancipated)
signed (or thumb printed if illiterate) an informed con-
sent form, before entering the study [29, 30]. The data
were anonymized.
Results
Out of the 285 pregnant women recruited in Nazoanga,
9 were excluded: 6 because of consent withdrawal and 3
because of twin pregnancy. Therefore, 276 participants
were included in the current analysis. Recruited women
were young (median age: 23 years), had several
Fig. 3 Agreement between z scores using Salomon or Intergrowth 21 equations. a: Head circumference. b: Femur length. c: Biparietal diameter.
d: Abdominal circumference. Intergrowth 21: International fetal and newborn growth consortium for the twenty-first century. Dashed horizontal
grey lower line represents the lower limit of agreement between the z-scores from Intergrowth 21st and Salomon equations. Solid horizontal
grey line represents the mean difference between the z-scores from Intergrowth 21st and Salomon equations. Dashed horizontal grey upper line
represents the upper limit of agreement between the z-scores from Intergrowth 21st and Salomon equations
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pregnancies (median gravidity: 3), and at inclusion had a
median gestational age of 25 weeks (Table 1).
Median and interquartile range (IQR) of the measured
parameters increased with increasing gestational age
(Fig. 1).
Visual comparison by scatter plots of Intergrowth 21st
‘s to Salomon’s z scores showed that they were underes-
timated in the low values of BPD (Fig. 2a), AC (Fig. 2b),
and HC (Fig. 2c), and overestimated in the high values
of AC (Fig. 2b), and HC (Fig. 2c); all z scores of FL were
overestimated (Fig. 2d).
The two sets of z scores agreed poorly except for HC.
The mean difference (− 0.01) was closed to zero and the
limits of agreement (− 0.60 and 0.59) were closed to the
prespecified values of − 0.5 and 0.5. (Fig. 3a). Reliability
ranged from good to excellent (see Additional file 1,
Supplemental Table 1).
There was a strong linear correlation between the z
scores by Intergrowth 21st equations and the z scores by
Salomon equations. The slopes of linear regression of z
scores using Intergrowth 21st equations over the z
scores using Salomon equations ranged from 1.11 for
BPD to 1.78 for AC (Fig. 4).
The percentages of fetal anthropometrics classified either
as small or large are reported in Table 2. Globally, the num-
ber of measurements considered as large was greater than
that of measurements considered as small, except for BPD.
Also, percentages of fetuses with abnormal z scores by
Intergrowth 21st equations were higher than those by Salo-
mon equations. The effect of replacing Salomon reference
by Intergrowth 21st standards was shown using AC as sur-
rogate of fetal size. Large fetuses (above the 90th percentile)
proportion using Salomon eqs. (2.9%) was decupled when
Intergrowth 21st equations were used (31.2%).
In the second trimester, the agreement between HC z
scores using Intergrowth 21st equations and z scores
using Salomon equations remained good: mean differ-
ence 0.03; limits of agreement − 0.62 and 0.68 (Table 3).
The proportions of large fetuses based on AC measure-
ments above the 90th percentile were 36.3% by
Fig. 4 Regression of Intergrowth 21 z-scores with Salomon z-scores. a: Biparietal diameter. b: Abdominal circumference. c: Head circumference. d:
Femur length. Intergrowth 21: International fetal and newborn growth consortium for the twenty-first century. Dashed oblique black line
represents the perfect agreement between the z-scores from Intergrowth 21st and Salomon equations. Solid oblique grey line represents the
linear regression fitted line
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Intergrowth 21st equations and 2.6% by Salomon equa-
tions. However, the greatest difference in large biometric
measurements between the four parameters was ob-
served in FL (6.8% and 54. 2%, using Salomon and Inter-
growth 21st equations respectively) (Table 4).
In the third trimester mean difference between HC z
scores was − 0.09 and limits of agreement were − 0.52
and 0.35 (Table 5). Large fetuses detected by AC z
scores above the 90th percentiles were 19.8 and 3.5%
using Intergrowth 21st and Salomon equations, respect-
ively (Table 6).
Discussion
The aim of our study was to determine the differences
between fetuses’ size patterns estimated by Salomon ref-
erences or Intergrowth 21st standards in a sub-Saharan
African rural population, rather than estimating the ac-
tual status of smallness or largeness.
The differences between the means of z-scores of the
four biometric parameters estimated by the two methods
were all statistically significant. Intergrowth 21st equa-
tions gave the greatest scores, particularly for FL. There-
fore, the charts agreed poorly, except for HC.
These findings revealed differences between our popula-
tion and the populations used for the charts [1, 10]. Indeed,
Salomon‘s chart was developed on the basis of a cohort of
pregnant women followed up in France which probably is
ethnically different from our cohort of Burkinabe pregnant
women, [16] possibly explaining the observed discrepancies
[12–14]. Nevertheless, the development of Intergrowth
21st equations included African pregnant women [27] but
had greater means of z-scores, meaning that other factors
than ethnicity could explain the differences observed. Inter-
growth 21st equations were derived on the basis of healthy,
well-nourished women [10] and thus describe growth
under optimal conditions [1, 10]. References of Salomon
imposed few constraints regarding adequacy of the nutri-
tional or health status [16]. Our study population included
malaria-infected pregnant women living in rural Burkina
Faso [29]; on average observed measures were more distant
from standards and closer to references, suggesting that
ideal fetal growth conditions were not fulfilled. Neverthe-
less, the negative means of BPD z-scores were probably due
to systematic variations in head measurement methods as
already shown in another publication [34]. BPD was ob-
tained by placing calipers in the center of the width of the
skull bone, from outer-to-outer and from outer-to-inner
margins, in the study of Salomon’s, Intergrowth 21st study
and in our study [16, 27, 32].
Despite these disparities, both charts agreed roughly
on HC measurements. This finding reinforces the choice
of HC as a single “non-fat marker” for comparison of
fetal size across populations [4, 10].
It was recently shown that FL z scores between
Intergrowth 21st and Salomon’s equations were
largely divergent in France, [34] a difference also ob-
served in our study that may be due to the evolution
in ultrasound technology [35]. Indeed, recent ultra-
sound equipment’s such as those used in the Inter-
growth 21st study have thinner beam and yield
Table 2 Fetuses with abnormal z scores using Intergrowth 21st or Salomon equations
Anthropometrics Abnormal z score n (%)
< 2.5th centile < 10th centile > 90th centile > 97.5th centile
Biparietal diameter
Intergrowth 21 10 (3.6) 39 (14.1) 1 (0.4) 1 (0.4)
Salomon 3 (1.1) 14 (5.1) 1 (0.4) 1 (0.4)
Mc Nemar test n.a < 0.001 n.a n.a
Abdominal circumference
Intergrowth 21 1 (0.4) 3 (1.1) 86 (31.2) 33 (12.0)
Salomon 0 (0.0) 1 (0.4) 8 (2.9) 2 (0.7)
Mc Nemar test n.a n.a < 0.001 < 0.001
Head circumference
Intergrowth 21 0 (0.0) 1 (0.4) 68 (24.6) 19 (6.9)
Salomon 0 (0.0) 0 (0.0) 52 (18.8) 4 (1.4)
Mc Nemar test n.a n.a < 0.001 < 0.001
Femur length
Intergrowth 21 2 (0.7) 6 (2.2) 137 (49.6) 49 (17.8)
Salomon 3 (1.1) 10 (3.6) 18 (6.5) 3 (1.1)
Mc Nemar test n.a n.a < 0.001 < 0.001
n.a not applicable; Intergrowth 21: international fetal and newborn growth consortium for the twenty-first century
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Table 3 Agreement and reliability of fetal biometrics z scores using Intergrowth 21st and Salomon equations in the second
trimester
Anthropometrics Mean ± SD p-value* Median (IQR) p-value† Range
Biparietal diameter
Intergrowth 21 − 0.48 ± 0.72 − 0.47 (− 0.98; − 0.04) −3.40; 3.11
Salomon − 0.15 ± 0.63 − 0.12 (− 0.60; 0.24) −2.68; 2.81
Difference − 0.33 ± 0.21 < 0.001 − 0.40 (− 0.48; − 0.22) < 0.001 − 0.72; 0.33
LOA − 0.74; 0.07
ICC 0.85
Abdominal circumference
Intergrowth 21 1.05 ± 1.18 0.95 (0.35; 1.59) −2.07; 9.90
Salomon 0.29 ± 0.63 0.23 (−0.03; 0.58) −1.37; 5.22
Difference 0.77 ± 0.60 < 0.001 0.69 (0.40; 1.01) < 0.001 − 0.70; 4.68
LOA − 0.40; 1.94
ICC‡ 0.54
Head circumference
Intergrowth 21 0.75 ± 0.81 0.72 (0.14; 1.29) −1.56; 4.24
Salomon 0.72 ± 0.61 0.67 (0.31; 1.14) −0.94; 3.36
Difference 0.03 ± 0.33 0.18 −0.02 (− 0.22; 0.23) 0.85 −0.62; 1.01
LOA −0.62; 0.68
ICC 0.89
Femur length
Intergrowth 21 1.21 ± 0.92 1.34 (0.63; 1.81) −1.53; 4.00
Salomon 0.36 ± 0.71 0.47 (−0.07; 0.77) −1.85; 2.57
Difference 0.85 ± 0.21 < 0.001 0.88 (0.73; 0.97) < 0.001 0.21; 1.43
LOA 0.43; 1.27
ICC 0.63
* Paired t test p value
† Wilcoxon signed ranks test p value
‡ Intraclass correlation calculation for abdominal circumference z scores excluded one participant with extreme values (9.9 using Intergrowth equations and 5.22
using Salomon equations)
LOA limits of agreement, ICC intraclass correlation coefficient
Table 4 Abnormal z scores using Intergrowth 21st or Salomon equations in the second trimester
Anthropometrics Abnormal z scores n (%)
< 2.5th centile < 10th centile > 90th centile > 97.5th centile
Biparietal diameter
Intergrowth 21 4 (2.1) 16 (8.4) 1 (0.5) 1 (0.5)
Salomon 1 (0.5) 4 (2.1) 1 (0.5) 1 (0.5)
Abdominal circumference
Intergrowth 21 1 (0.5) 3 (1.6) 69 (36.3) 28 (14.7)
Salomon 0 (0) 1 (0.5) 5 (2.6) 2 (1.1)
Head circumference
Intergrowth 21 0 (0) 1 (0.5) 49 (25.8) 15 (7.9)
Salomon 0 (0) 0 (0) 34 (17.9) 3 (1.6)
Femur length
Intergrowth 21 0 (0) 2 (1.1) 103 (54.2) 32 (16.8)
Salomon 0 (0) 4 (2.1) 13 (6.8) 2 (1.1)
Bihoun et al. BMC Pregnancy and Childbirth          (2020) 20:492 Page 8 of 12
Table 5 Agreement and reliability of fetal biometrics z scores using Intergrowth 21st and Salomon equations in the third trimester
Anthropometrics Mean ± SD p-value* Median (IQR) p-value† Range
Biparietal diameter
Intergrowth 21 −0.91 ± 0.70 −0.89 (−1.31; −0.44) −2.62; 0.78
Salomon − 0.53 ± 0.64 −0.49 (− 0.90; − 0.11) −2.10; 1.00
Difference −0.39 ± 0.07 < 0.001 −0.38 (− 0.44; − 0.34) < 0.001 −0.53; − 0.22
LOA −0.52; − 0.25
ICC 0.85
Abdominal circumference
Intergrowth 21 0.81 ± 0.71 0.75 (0.29; 1.21) −0.95; 2.89
Salomon 0.35 ± 0.43 0.36 (0.02; 0.63) −0.68; 1.45
Difference 0.45 ± 0.31 < 0.001 0.37 (0.25; 0.64) < 0.001 −0.27; 1.48
LOA −0.16; 1.07
ICC 0.66
Head circumference
Intergrowth 21 0.76 ± 0.70 0.70 (0.39; 1.21) −0.87; 2.49
Salomon 0.85 ± 0.48 0.79 (0.58; 1.17) −0.28; 2.05
Difference −0.09 ± 0.22 < 0.001 − 0.09 (− 0.18; 0.07) 0.001 −0.59; 0.44
LOA −0.52; 0.35
ICC 0.92
Femur length
Intergrowth 21 1.09 ± 1.15 1.15 (0.53; 1.75) −2.44; 3.55
Salomon 0.07 ± 0.90 0.13 (−0.38; 0.55) − 2.54; 2.02
Difference 1.02 ± 0.26 < 0.001 1.04 (0.91; 1.16) < 0.001 0.10; 1.53
LOA 0.50; 1.53
ICC 0.65
* Paired t test p value
† Wilcoxon signed ranks test p value
LOA limits of agreement, ICC intraclass correlation coefficient
Table 6 Abnormal z scores using Intergrowth 21st or Salomon equations in the third trimester
Anthropometrics Abnormal z scores n (%)
< 2.5th centile < 10th centile > 90th centile > 97.5th centile
Biparietal diameter
Intergrowth 21 6 (7.0) 23 (26.7) 0(0) 0(0)
Salomon 2 (2.3) 10 (11.6) 0(0) 0(0)
Abdominal circumference
Intergrowth 21 0(0) 0 (0) 17 (19.8) 5 (5.8)
Salomon 0(0) 0 (0) 3 (3.5) 0(0)
Head circumference
Intergrowth 21 0(0) 0 (0) 19 (22.1) 4 (4.7)
Salomon 0(0) 0 (0) 18 (20.9) 1 (1.2)
Femur length
Intergrowth 21 2 (2.3) 4 (4.7) 34 (39.5) 17 (19.8)
Salomon 3 (3.5) 6 (7.0) 5 (5.8) 1 (1.2)
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smaller FL [35, 36] than older machines as in our
study [31] and in Salomon’s [16].
When AC was used as a proxy of fetal size estimation
[2], the proportions of small fetuses were low for both
charts which may indicate the difficulty ultrasonography
has in identifying small fetuses [15, 37]. However, the
proportions of both small and large fetuses were higher
with Intergrowth 21st equations than with Salomon
equations and a similar trend was remarked with HC,
suggesting the tendency of Intergrowth 21st equations
to underestimate the size in small measurements and to
overestimate it in high measurements [3, 34]. Thus,
the choice of one or another of these references
would implies very different medical interventions,
follow-up, and resources allocation as well as stress
put on patients [4, 27].
It is well documented that pregnancies affected by
malaria, as in our study, are subject to fetal growth re-
striction [31, 38]. Thus, the number of small fetuses was
expected to be high even if differences would be found
between the charts. Surprisingly, this number was very
low and the number of large fetuses was high. We sus-
pect gestational age determination to be a possible cause
of such situation. Indeed, pregnancies were dated late
owing to the study design, [29] using a combination of
fetal biometry measurements [33]. Late dating is less ac-
curate than early dating. However, this is common prac-
tice in sub-Saharan Africa where almost three out of four
pregnant women attend their first antenatal clinic during
the second or third trimester, or not at all [39]. Although
the combination of fetal anthropometric measurement is
the recommended method at this stage of pregnancy, [40]
it could produce redundant relationship when used for de-
termining both gestational age and fetal size [4]. This is of
particular concern in areas where malaria in pregnancy is
common such as in Burkina Faso [41]. Gestational age
could be underestimated in case of symmetric fetal growth
restriction [33], hiding the adverse effect of malaria [42].
However, the difficulty for estimating the gestational age
applies to both sets of equations when calculating z scores.
Therefore, the differences between the charts are probably
not due only to pregnancy dating problems, as shown by
the positive and significant slopes in linear regressions. In
addition, pregnant women included in this clinical trial,
besides malaria, did not have any other chronic or major
disease with adverse effect on fetal growth [29].
This is a post-hoc analysis and thus, has some limita-
tions. Physicians performing the ultrasound scans are not
professional sonographers even if trained ad hoc. In
addition, the study design was not conceived to evaluate
two different methods for the assessment of fetal biom-
etry. Moreover, the use of European references equations
may not be appropriate for African populations. Gesta-
tional age determined in late pregnancy is also another
limitation because of less accuracy. Our study population
prone to malaria was quite selected and this maybe intro-
duce a bias. However, a recent study showed that the dif-
ference between the two charts remained while using fetal
biometric measurements from pregnant women as healthy
as those in the Intergrowth 21st study [43].
Conclusion
The agreement between Intergrowth 21st and Salomon
equations, besides HC, was poor. This would imply dif-
ferent clinical decisions regarding the management of
the pregnancy and the delivery. Encouraging women to
attend antenatal clinics earlier and to use preventive
measures against malaria such as long-lasting insecti-
cidal bed nets, would probably be much more beneficial
than just dating gestation or determining fetal size.
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